Technical Analysis for GBIO - Generation Bio Co.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 2.75 | -1.08% | -0.03 |
Earnings due: May 8
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Resistance | Bearish | -1.08% | |
Fell Below 50 DMA | Bearish | -1.08% | |
Wide Bands | Range Expansion | -1.08% | |
Below Lower BB | Weakness | -1.08% | |
Down 3 Days in a Row | Weakness | -1.08% | |
Lower Bollinger Band Touch | Weakness | -1.08% | |
Oversold Stochastic | Weakness | -1.08% | |
Fell Below 200 DMA | Bearish | -7.72% | |
New Downtrend | Bearish | -7.72% | |
50 DMA Support | Bullish | -7.72% |
Alert | Time |
---|---|
Possible NR7 | about 3 hours ago |
Up 2% | about 5 hours ago |
60 Minute Opening Range Breakout | about 6 hours ago |
Fell Below Previous Day's Low | about 6 hours ago |
Down 2 % | about 6 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/08/2024
Generation Bio Co. Description
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.98 |
52 Week Low | 0.86 |
Average Volume | 253,428 |
200-Day Moving Average | 3.00 |
50-Day Moving Average | 2.99 |
20-Day Moving Average | 3.68 |
10-Day Moving Average | 3.63 |
Average True Range | 0.36 |
RSI (14) | 38.27 |
ADX | 41.51 |
+DI | 21.11 |
-DI | 25.06 |
Chandelier Exit (Long, 3 ATRs) | 3.58 |
Chandelier Exit (Short, 3 ATRs) | 3.82 |
Upper Bollinger Bands | 4.59 |
Lower Bollinger Band | 2.78 |
Percent B (%b) | 0.0 |
BandWidth | 48.98 |
MACD Line | 0.05 |
MACD Signal Line | 0.23 |
MACD Histogram | -0.1803 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.27 | ||||
Resistance 3 (R3) | 3.31 | 3.19 | 3.19 | ||
Resistance 2 (R2) | 3.19 | 3.07 | 3.17 | 3.16 | |
Resistance 1 (R1) | 2.99 | 2.99 | 2.93 | 2.94 | 3.13 |
Pivot Point | 2.87 | 2.87 | 2.84 | 2.85 | 2.87 |
Support 1 (S1) | 2.66 | 2.74 | 2.60 | 2.62 | 2.43 |
Support 2 (S2) | 2.54 | 2.67 | 2.52 | 2.40 | |
Support 3 (S3) | 2.34 | 2.54 | 2.37 | ||
Support 4 (S4) | 2.29 |